4/10
03:42 pm
iova
Iovance Biotherapeutics (IOVA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
Low
Report
Iovance Biotherapeutics (IOVA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
4/10
03:16 pm
iova
Rating for IOVA
Low
Report
Rating for IOVA
3/5
10:03 am
iova
Rating for IOVA
Medium
Report
Rating for IOVA
2/25
10:56 am
iova
Rating for IOVA
High
Report
Rating for IOVA
2/25
10:56 am
iova
Rating for IOVA
High
Report
Rating for IOVA